anmelden
SMI Expanded
1.856,20
PKT
+6,64
PKT
+0,36
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.12.16 | Swiss Re Hold | Société Générale Group S.A. (SG) | |
| 15.12.16 | UBS buy | Kepler Cheuvreux | |
| 15.12.16 | UBS Reduce | Kepler Cheuvreux | |
| 14.12.16 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 14.12.16 | UBS Hold | Deutsche Bank AG | |
| 14.12.16 | UBS Hold | Deutsche Bank AG | |
| 14.12.16 | Nestlé Neutral | BNP PARIBAS | |
| 14.12.16 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
| 13.12.16 | Nestlé buy | Deutsche Bank AG | |
| 13.12.16 | Novartis Hold | Deutsche Bank AG | |
| 13.12.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Swiss Re buy | Deutsche Bank AG | |
| 13.12.16 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 13.12.16 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 13.12.16 | Novartis buy | HSBC | |
| 13.12.16 | Zurich Insurance Outperform | Credit Suisse Group | |
| 12.12.16 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 12.12.16 | Zurich Insurance overweight | Barclays Capital | |
| 12.12.16 | Swiss Re Underweight | Barclays Capital | |
| 12.12.16 | UBS overweight | JP Morgan Chase & Co. | |
| 12.12.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 12.12.16 | Swiss Re Underperform | Credit Suisse Group | |
| 09.12.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.12.16 | UBS buy | HSBC | |
| 09.12.16 | Holcim buy | Deutsche Bank AG | |
| 09.12.16 | UBS Hold | Deutsche Bank AG | |
| 09.12.16 | UBS buy | UBS AG | |
| 08.12.16 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 08.12.16 | UBS overweight | JP Morgan Chase & Co. | |
| 08.12.16 | Swiss Re Underperform | Jefferies & Company Inc. | |
| 08.12.16 | Swiss Re buy | Deutsche Bank AG | |
| 08.12.16 | UBS buy | Kepler Cheuvreux | |
| 08.12.16 | UBS neutral | Morgan Stanley | |
| 08.12.16 | Zurich Insurance buy | HSBC | |
| 08.12.16 | Roche buy | UBS AG | |
| 08.12.16 | Novartis Neutral | UBS AG | |
| 08.12.16 | UBS Sell | S&P Capital IQ | |
| 08.12.16 | UBS buy | Goldman Sachs Group Inc. | |
| 07.12.16 | Swiss Re Outperform | Robert W. Baird & Co. Incorporated |